These mutations have been associated with glucose transporters deficiency, lower serum insulin levels, glucose malabsorption and NIDDM making them attractive molecular targets for insulin resistance and glucose abnormalities [44] (For review, the Human Gene Mutation Database). This evidence concerns the gene INS and Insulin resistance.